Skip to main content
. 2019 Jan 7;14(1):e0210024. doi: 10.1371/journal.pone.0210024

Table 3. Relative risk of developing glucose intolerance (prediabetes and type 2 diabetes) among the study cohort.

Risk Factor RR (95% C.I.) p- value BCa RR(95% C.I.) p-value
Age (years) 1.02(0.98–1.05) 0.41 1.01 (0.98–1.05) 0.43
parity
primiparous 1
multiparous 1.09 (0.69–1.69) 0.71 0.90 (0.55–1.49) 0.69
Family history of DM
no 1
yes 1.41 (0.90–2.20) 0.13 1.27(0.77–2.13) 0.31
Pre-pregnancy BMI
Less than 25 1
25.1–29.9 1.11 (0.63–1.94) 0.72 o.85(0.43–1.54) 0.59
30+ 1.28 (0.81–2.03) 0.29 0.95 (0.55–1.69) 0.87
Pregnancy fasting glucose level 1.30 (0.99–1.69) 0.05 1.21 (0.91–1.69) 0.18
GDM
No 1
yes 1.91 (1.31–2.78) <0.01 1.74 (1.06–2.84) 0.01
Treatment of GDM
Diet 1
insulin 1.37 (0.56–3.35) 0.48 1.49(0.53–3.85) 0.42
Current BMI (kg/m2)
Less than 25 1
25.1–29.9 1.31 (0.74–2.32) 0.34 1.22 (0.68–2.26) 0.49
≥ 30 1.79 (1.17–2.97) 0.02 1.69 (1.01–3.11) 0.04
Diastolic Blood Pressure 1.03 (1.001–1.066) 0.04 1.04 (1.01–1.09) 0.03

RR, Relative risk; BCa C.I., Bias Corrected and accelerated confidence interval; C.I., Confidence intervals; DM, Diabetes mellitus; GDM, Gestational Diabetes.